Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Edmond J. Feris"'
Autor:
Edmond J. Feris, Liliana Encinales, Carlos Awad, Joel N.H. Stern, Inna Tabansky, Luis Jiménez-Alvarez, Gustavo Ramírez-Martínez, Alfredo Cruz-Lagunas, Karen Bobadilla, Eduardo Márquez, Julio Granados-Montiel, Tatiana S. Rodriguez-Reyna, Marcelo Fernandez-Vina, Julio Granados, Joaquin Zuñiga, Edmond J. Yunis
Publikováno v:
International Journal of Infectious Diseases, Vol 43, Iss C, Pp 21-24 (2016)
Objectives: To determine the effect of anti-tuberculin antibodies in the T-cell proliferation in response to tuberculin and Candida antigens in individuals with different levels of tuberculosis (TB) risk. Methods: Sixteen high-risk TB individuals, 30
Externí odkaz:
https://doaj.org/article/b3be22d50d3544bf96d2867de2b2b3d4
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272771 (2022)
MYC is one of the most dysregulated oncogenes and is thought to be fundamental to tumor formation and/or maintenance in many cancer types. This dominant pro-tumor activity makes MYC an attractive target for cancer therapy. However, MYC is a transcrip
Externí odkaz:
https://doaj.org/article/ca75accf74d641108228b7a91f836076
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0225784 (2019)
Our primary goal is to therapeutically target the oncogenic transcription factor MYC to stop tumor growth and cancer progression. Here, we report aspects of the biophysical states of the MYC protein and its interaction with one of the best-characteri
Externí odkaz:
https://doaj.org/article/26a7772084ca417296973f55f6a1d8aa
Publikováno v:
Oncotarget
Mechanism-based targeted therapies have exhibited remarkable success in treating otherwise untreatable or unresectable cancers. Novel targeted therapies that correct dysregulated transcriptional programs in cancer are an unmet medical need. The trans
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 12, p e0225784 (2019)
PLoS ONE, Vol 14, Iss 12, p e0225784 (2019)
Our primary goal is to therapeutically target the oncogenic transcription factor MYC to stop tumor growth and cancer progression. Here, we report aspects of the biophysical states of the MYC protein and its interaction with one of the best-characteri
Publikováno v:
Cancer Biology & Therapy. 17:291-299
Microtubule targeting agents, such as vinblastine, are usually thought to arrest cells in mitosis and subsequently induce apoptosis. However, they can also cause rapid induction of apoptosis in a cell-cycle phase independent manner. BNC105 is a novel
Autor:
Joaquín Zúñiga, Chester A. Alper, Daniel Terreros, Derek Middleton, Julio Granados-Montiel, Janardan P. Pandey, Edmond J. Yunis, Edmond J. Feris, Alfredo Cruz-Lagunas, Olga P. Clavijo, Charles E. Larsen, Jose Azocar
Publikováno v:
Immunobiology. 216:686-691
Genetic interactions between natural killer cells (NK) immunoglobulin-like receptor (KIR) genes and immunoglobulin allotypes have been previously reported in type 2 diabetes mellitus (DM) patients. Puerto Rican Americans with a history of intravenous
Autor:
Alfredo Cruz-Lagunas, Karen Bobadilla, Julio Granados-Montiel, Gustavo Ramírez-Martínez, Joaquín Zúñiga, Edmond J. Yunis, Julio Granados, Liliana Encinales, Tatiana S. Rodriguez-Reyna, Eduardo Márquez, Edmond J. Feris, Marcelo Fernandez-Vina, Luis Jiménez-Alvarez, Joel N. H. Stern, Carlos Awad, Inna Tabansky
Publikováno v:
International Journal of Infectious Diseases, Vol 43, Iss C, Pp 21-24 (2016)
Summary Objectives To determine the effect of anti-tuberculin antibodies in the T-cell proliferation in response to tuberculin and Candida antigens in individuals with different levels of tuberculosis (TB) risk. Methods Sixteen high-risk TB individua